BACK

Tom Babich

Head of Capital Markets

New York Office  |  tom.babich@torreya.com   |   212.257.5811

Tom Babich, Head of Capital Markets at Torreya, leads funding transactions in the United States, including private equity investments, debt placements and royalty monetizations. He also has experience working on asset divestitures, mergers, and company sales.

Notable transactions on which Tom has worked include the Scidose, Opiant, and Xoma royalty sales in 2016; the New Mountain Capital majority equity investment in Topix Pharmaceuticals; and debt raises for Crown Labs, Amerigen, PDI, and Trimel.

Tom joined Torreya in 2009. Previously, he was a professional baseball player.

He received a B.A. in economics from Harvard University.

Tom is a director of Noria Therapeutics and is active with New York Cares and the Xaverian Brothers Alumni Association.